CA1316180C - L-dopa derivatives or their acid addition salts, process for producing same and their use - Google Patents
L-dopa derivatives or their acid addition salts, process for producing same and their useInfo
- Publication number
- CA1316180C CA1316180C CA000577320A CA577320A CA1316180C CA 1316180 C CA1316180 C CA 1316180C CA 000577320 A CA000577320 A CA 000577320A CA 577320 A CA577320 A CA 577320A CA 1316180 C CA1316180 C CA 1316180C
- Authority
- CA
- Canada
- Prior art keywords
- dopa
- group
- acid addition
- addition salt
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP234,299/87 | 1987-09-18 | ||
| JP23429987 | 1987-09-18 | ||
| JP31,260/88 | 1988-02-13 | ||
| JP3126088 | 1988-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1316180C true CA1316180C (en) | 1993-04-13 |
Family
ID=26369718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000577320A Expired - Fee Related CA1316180C (en) | 1987-09-18 | 1988-09-14 | L-dopa derivatives or their acid addition salts, process for producing same and their use |
Country Status (12)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003070245A1 (en) * | 2002-02-15 | 2003-08-28 | Darpharma, Inc. | Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
| WO2004052841A1 (en) * | 2002-12-06 | 2004-06-24 | Xenoport, Inc. | Carbidopa prodrugs and uses thereof |
| US6970629B2 (en) | 2002-12-19 | 2005-11-29 | Corning Cable Systems Llc | Optical tube assembly having a dry insert and methods of making the same |
| US7471862B2 (en) | 2002-12-19 | 2008-12-30 | Corning Cable Systems, Llc | Dry fiber optic cables and assemblies |
| US20090190890A1 (en) | 2002-12-19 | 2009-07-30 | Freeland Riley S | Fiber optic cable having a dry insert and methods of making the same |
| IL154318A (en) | 2003-02-06 | 2010-05-31 | Sarah Herzog Memorial Hospital | Pharmaceutical compositions for the treatment of movement disorders |
| KR101287297B1 (ko) | 2004-06-04 | 2013-07-23 | 제노포트 인코포레이티드 | 레보도파 프로드러그, 및 그의 조성물 및 용도 |
| US7323585B2 (en) * | 2004-06-04 | 2008-01-29 | Xenoport, Inc. | Levodopa prodrugs, and compositions and uses thereof |
| AU2006322051B2 (en) * | 2005-12-05 | 2011-09-29 | Xenoport, Inc. | Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| CA2673336A1 (en) | 2006-12-21 | 2008-06-26 | Xenoport, Inc. | Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use |
| US7829592B2 (en) | 2006-12-21 | 2010-11-09 | Xenoport, Inc. | Catechol protected levodopa diester prodrugs, compositions, and methods of use |
| US8399513B2 (en) | 2008-10-20 | 2013-03-19 | Xenoport, Inc. | Levodopa prodrug mesylate hydrate |
| CN102186804A (zh) | 2008-10-20 | 2011-09-14 | 克塞诺波特公司 | 合成左旋多巴酯前药的方法 |
| KR101025612B1 (ko) * | 2008-11-10 | 2011-03-30 | 한국해양연구원 | 신규 화합물인 Ｒａｍａｌｉｎ 및 그 용도 |
| JP2013520521A (ja) | 2009-11-09 | 2013-06-06 | ゼノポート，インコーポレーテッド | レボドパプロドラッグの医薬組成物及び経口剤形並びに使用方法 |
| ES2614179T3 (es) | 2010-03-04 | 2017-05-30 | Orion Corporation | Uso de levodopa, carbidopa y entacapona para el tratamiento de la enfermedad de Parkinson |
| CN103694127B (zh) * | 2013-12-30 | 2015-04-01 | 上海交通大学 | 链霉菌属菌种所产的化合物及该化合物的制备方法和应用 |
| SG11201703170RA (en) | 2014-10-21 | 2017-05-30 | Abbvie Inc | Carbidopa and l-dopa prodrugs and their use to treat parkinson's disease |
| KR20180004756A (ko) | 2015-05-06 | 2018-01-12 | 신애질 코포레이션 | 약물 입자를 함유하는 제약 현탁액, 그의 투여를 위한 장치, 및 그의 사용 방법 |
| WO2019097120A1 (en) | 2017-11-16 | 2019-05-23 | Orion Corporation | New use and pharmaceutical dosage forms |
| BR112021009353A2 (pt) | 2018-11-15 | 2021-11-23 | Abbvie Inc | Formulações farmacêuticas para administração subcutânea |
| US20220213128A1 (en) * | 2021-01-03 | 2022-07-07 | RockGen Therapeutics LLC | L-Dopa Enhanced with a Neuroprotective Agent as a Therapy for Parkinson's Disease |
| US20240415800A1 (en) * | 2021-10-11 | 2024-12-19 | The Johns Hopkins University | Dopa and caffeic acid analogs as novel gcpii inhibitors |
| WO2025075499A1 (en) | 2023-10-02 | 2025-04-10 | Universiteit Van Amsterdam | Reducing dopamine feed-back inhibition in dopaminergic cells by tadalafil. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US393923A (en) * | 1888-12-04 | Samuel preston | ||
| US2868818A (en) * | 1953-12-15 | 1959-01-13 | Merck & Co Inc | Alpha methyl phenylalanines |
| US3725470A (en) * | 1969-05-14 | 1973-04-03 | Hoffmann La Roche | Amino acid derivatives |
| CH562199A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1970-10-30 | 1975-05-30 | Hoffmann La Roche | |
| BE793426A (fr) * | 1971-12-28 | 1973-06-28 | Lannacher Heilmittel G M B H | Derives de phenylalanine |
| US3983138A (en) * | 1973-09-25 | 1976-09-28 | Merck & Co., Inc. | Amino acid esters |
| US3891696A (en) * | 1973-11-02 | 1975-06-24 | Interx Research Corp | Novel, transient pro-drug forms of l-dopa |
| US3939253A (en) * | 1973-11-02 | 1976-02-17 | Interx Research Corporation | Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease |
| US4401676A (en) * | 1977-06-01 | 1983-08-30 | Merck & Co., Inc. | Novel α-amino acids |
| US4311706A (en) * | 1980-01-22 | 1982-01-19 | Interx Research Corporation | Novel dopa/dopamine prodrugs |
-
1988
- 1988-09-10 JP JP63227086A patent/JPH02138A/ja active Granted
- 1988-09-14 CA CA000577320A patent/CA1316180C/en not_active Expired - Fee Related
- 1988-09-15 IL IL87765A patent/IL87765A0/xx unknown
- 1988-09-16 EP EP88115183A patent/EP0309827B1/en not_active Expired - Lifetime
- 1988-09-16 PT PT88526A patent/PT88526B/pt not_active IP Right Cessation
- 1988-09-16 KR KR1019880012032A patent/KR890005031A/ko not_active Withdrawn
- 1988-09-16 DE DE8888115183T patent/DE3867403D1/de not_active Expired - Lifetime
- 1988-09-16 AU AU22340/88A patent/AU2234088A/en not_active Abandoned
- 1988-09-16 DK DK517588A patent/DK517588A/da not_active Application Discontinuation
- 1988-09-16 AT AT88115183T patent/ATE71083T1/de active
- 1988-09-16 US US07/245,348 patent/US4966915A/en not_active Expired - Fee Related
- 1988-09-17 CN CN88107165A patent/CN1032785A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0541626B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-06-24 |
| IL87765A0 (en) | 1989-02-28 |
| EP0309827A1 (en) | 1989-04-05 |
| DK517588A (da) | 1989-03-19 |
| DE3867403D1 (de) | 1992-02-13 |
| DK517588D0 (da) | 1988-09-16 |
| EP0309827B1 (en) | 1992-01-02 |
| PT88526A (pt) | 1988-10-01 |
| JPH02138A (ja) | 1990-01-05 |
| KR890005031A (ko) | 1989-05-11 |
| US4966915A (en) | 1990-10-30 |
| ATE71083T1 (de) | 1992-01-15 |
| AU2234088A (en) | 1989-03-23 |
| PT88526B (pt) | 1992-11-30 |
| CN1032785A (zh) | 1989-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1316180C (en) | L-dopa derivatives or their acid addition salts, process for producing same and their use | |
| ES2244666T3 (es) | Derivados de acidos 3-(heteroaril-acetamido)-2-oxoazetidina-1-sulfonicos utilizados como agentes antibacterianos. | |
| US5416066A (en) | 1,4-benzothiazepine derivatives | |
| KR100347423B1 (ko) | 구아니딘알킬-1,1-비스포스폰산유도체,이의제조방법및이를함유하는약제 | |
| WO2018157842A1 (zh) | 2-(取代苯氨基)苯甲酸类fto抑制剂治疗白血病的用途 | |
| KR20120028877A (ko) | 리버스턴 유사체의 신규한 화합물 및 그 제조방법과 용도 | |
| RU2720488C2 (ru) | Замещенные амино шестичленные насыщенные гетероалициклы в качестве ингибиторов dpp-iv длительного действия | |
| JP5128959B2 (ja) | 新規ヒスチジン誘導体 | |
| HU205365B (en) | Process for producing lysosphingolipid derivatives and pharmaceutical compositions comprising such compounds | |
| KR19990007203A (ko) | 아포 비-분비/엠티피 억제제 하이드로클로라이드 염 | |
| CA2136108A1 (en) | Carbostyril derivatives as matrix metalloproteinases inhibitors | |
| CA2135597A1 (en) | Glutaminase inhibitor | |
| WO1991016337A1 (en) | S-(lower fatty acid)-substituted glutathione derivative | |
| CN103626825A (zh) | 靶向肝脏的糖原磷酸化酶抑制剂胆酸类衍生物、其制备方法及医药用途 | |
| RU2303041C2 (ru) | Твердые соли бензазепиновых соединений и их применение при получении фармацевтических соединений | |
| RO111369B1 (ro) | Derivati dipeptidici cu activitate antihipertensiva si procedee de obtinere a acestora | |
| NZ238631A (en) | Preparation of antibacterial beta-lactam derivatives: compounds produced thereby | |
| WO2006132438A1 (ja) | １，３－ベンゾチアジノン誘導体およびその用途 | |
| TWI424843B (zh) | 新穎組胺酸衍生物 | |
| KR20120084790A (ko) | 치환 페닐알칸산의 신규 결정 및 제조 방법 | |
| JP5121018B2 (ja) | 新規ヒスチジン誘導体 | |
| JP2005060379A (ja) | 複素環式化合物からなる医薬 | |
| JP2004137185A (ja) | チオフェン骨格を有する抗菌剤 | |
| JP3757024B2 (ja) | イソクマリン誘導体およびそれらの製薬学的組成物 | |
| KR101214435B1 (ko) | 나테글리니드의 제조 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |